Sleep quality in glaucoma patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 Oct 2024
Historique:
received: 30 05 2024
accepted: 14 10 2024
medline: 27 10 2024
pubmed: 27 10 2024
entrez: 27 10 2024
Statut: epublish

Résumé

The purpose of this study is to objectively assess by polysomnography total sleep time and sleep macrostructure in glaucomatous versus non-glaucomatous individuals after adjusting for possible confounding factors affecting the quality of sleep. This is an observational, prospective, single-center, case-controlled study using a sleep research database (MARS e-Cohort) collecting clinical data, comorbidities, medications, and sleep studies of glaucomatous and non-glaucomatous individuals. The diagnosis of glaucoma was confirmed with a full comprehensive ophthalmological examination including a visual field test. Total sleep time and the main sleep parameters (time spent in stages 1, 2, 3 and 4, microarousals, apnea-hypopnea index, and indices of hypoxic burden) were compared in glaucomatous and non-glaucomatous individuals after adjusting for age, anthropometric data, and comorbidities. The study included 33 glaucomatous and 66 non-glaucomatous individuals. The median total sleep time was 325 min [273; 398] for the control group and 311 min [244; 349] for the glaucoma group. After adjusting for the potential confounding factors, there was no significant difference in total sleep time (p = 0.3) and other sleep parameters between the control group and the glaucoma group. The sleep macrostructure was comparable in the glaucomatous and non-glaucomatous individuals after careful adjustment for confounders.

Identifiants

pubmed: 39462008
doi: 10.1038/s41598-024-76368-z
pii: 10.1038/s41598-024-76368-z
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

25593

Informations de copyright

© 2024. The Author(s).

Références

Weinreb, R. N., Aung, T. & Medeiros, F. A. The pathophysiology and Treatment of Glaucoma. JAMA. 311, 1901–1911 (2014).
doi: 10.1001/jama.2014.3192 pubmed: 24825645 pmcid: 4523637
Resnikoff, S. et al. Global data on visual impairment in the year 2002. Bull. World Health Organ. 9 (2004).
Quigley, H. A. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80, 389–393 (1996).
doi: 10.1136/bjo.80.5.389 pubmed: 8695555 pmcid: 505485
Gracitelli, C. P. B. & Paranhos, A. Jr. Can glaucoma affect sleep quality? Arq. Bras. Oftalmol 78 (2015).
Provencio, I. et al. A novel human opsin in the inner retina. J. Neurosci. Off J. Soc. Neurosci. 20, 600–605 (2000).
doi: 10.1523/JNEUROSCI.20-02-00600.2000
Li, R. S. et al. Melanopsin-expressing retinal ganglion cells are more Injury-Resistant in a chronic ocular hypertension model. Invest. Ophthalmol. Vis. Sci. 47, 2951–2958 (2006).
doi: 10.1167/iovs.05-1295 pubmed: 16799038
Feigl, B., Mattes, D., Thomas, R. & Zele, A. J. Intrinsically photosensitive (Melanopsin) retinal ganglion cell function in Glaucoma. Invest. Ophthalmol. Vis. Sci. 52, 4362–4367 (2011).
doi: 10.1167/iovs.10-7069 pubmed: 21498620
Obara, E. A., Hannibal, J., Heegaard, S. & Fahrenkrug, J. Loss of Melanopsin-expressing retinal ganglion cells in severely staged Glaucoma patients. Invest. Ophthalmol. Vis. Sci. 57, 4661–4667 (2016).
doi: 10.1167/iovs.16-19997 pubmed: 27583827
Møller, M. & Baeres, F. M. The anatomy and innervation of the mammalian pineal gland. Cell. Tissue Res. 309, 139–150 (2002).
doi: 10.1007/s00441-002-0580-5 pubmed: 12111544
Wang, H., Zhang, Y., Ding, J. & Wang, N. Changes in the circadian rhythm in patients with primary Glaucoma. PLOS ONE. 8, e62841 (2013).
doi: 10.1371/journal.pone.0062841 pubmed: 23658653 pmcid: 3639222
Ra, S., Ayaki, M., Yuki, K., Tsubota, K. & Negishi, K. Dry eye, sleep quality, and mood status in glaucoma patients receiving prostaglandin monotherapy were comparable with those in non-glaucoma subjects. PLoS ONE. 12, e0188534 (2017).
doi: 10.1371/journal.pone.0188534 pubmed: 29176799 pmcid: 5703517
Hodapp, E., Parrish, R. K. & Anderson, D. R. Clinical Decisions in Glaucoma (Mosby, 1993).
Berry, R. B. et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated events. Deliberations of the Sleep Apnea definitions Task Force of the American Academy of Sleep Medicine. J. Clin. Sleep. Med. JCSM off Publ Am. Acad. Sleep. Med. 8, 597–619 (2012).
Johns, M. W. A New Method for Measuring Daytime Sleepiness: the Epworth Sleepiness Scale. Sleep. 14, 540–545 (1991).
doi: 10.1093/sleep/14.6.540 pubmed: 1798888
Gracitelli, C. P. B. et al. Relationship between Daytime Sleepiness and Intrinsically Photosensitive Retinal Ganglion Cells in Glaucomatous Disease. J. Ophthalmol. 5317371 (2016). (2016).
Gracitelli, C. P. B. et al. Intrinsically photosensitive retinal ganglion cell activity is Associated with decreased sleep quality in patients with Glaucoma. Ophthalmology. 122, 1139–1148 (2015).
doi: 10.1016/j.ophtha.2015.02.030 pubmed: 25858174
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R. & Kupfer, D. J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 28, 193–213 (1989).
doi: 10.1016/0165-1781(89)90047-4 pubmed: 2748771
Ayaki, M., Shiba, D., Negishi, K. & Tsubota, K. Depressed visual field and mood are associated with sleep disorder in glaucoma patients. Sci. Rep. 6, 25699 (2016).
doi: 10.1038/srep25699 pubmed: 27168309 pmcid: 4863426
Ma, X. P., Shen, M. Y., Shen, G. L., Qi, Q. R. & Sun, X. H. Melatonin concentrations in serum of primary glaucoma patients. Int. J. Ophthalmol. 11, 1337–1341 (2018).
pubmed: 30140638 pmcid: 6090119
Alvaro, P. K., Roberts, R. M. & Harris, J. K. A systematic review assessing bidirectionality between sleep disturbances, anxiety, and Depression. Sleep. 36, 1059–1068 (2013).
doi: 10.5665/sleep.2810 pubmed: 23814343 pmcid: 3669059

Auteurs

Louise Bec (L)

Department of Ophthalmology, Grenoble-Alpes University Hospital, CS 10217, 38043, Grenoble Cedex 09, France.

Romain Herber (R)

Department of Ophthalmology, Grenoble-Alpes University Hospital, CS 10217, 38043, Grenoble Cedex 09, France.

Sébastien Bailly (S)

HP2 Laboratory, INSERM U1300, Univ. Grenoble Alpes, Grenoble, France.

Thi Hong Van Ngo (TH)

HP2 Laboratory, INSERM U1300, Univ. Grenoble Alpes, Grenoble, France.

Renaud Tamisier (R)

HP2 Laboratory, INSERM U1300, Univ. Grenoble Alpes, Grenoble, France.
Pôle Thorax et Vaisseaux, Grenoble-Alpes University Hospital, La Tronche, France.

Jean-Louis Pépin (JL)

HP2 Laboratory, INSERM U1300, Univ. Grenoble Alpes, Grenoble, France.
Pôle Thorax et Vaisseaux, Grenoble-Alpes University Hospital, La Tronche, France.

Florent Aptel (F)

Department of Ophthalmology, Grenoble-Alpes University Hospital, CS 10217, 38043, Grenoble Cedex 09, France.
HP2 Laboratory, INSERM U1300, Univ. Grenoble Alpes, Grenoble, France.

Christophe Chiquet (C)

Department of Ophthalmology, Grenoble-Alpes University Hospital, CS 10217, 38043, Grenoble Cedex 09, France. cchiquet@chu-grenoble.fr.
HP2 Laboratory, INSERM U1300, Univ. Grenoble Alpes, Grenoble, France. cchiquet@chu-grenoble.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH